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ABSTRACT 
 
Implants are medical devices that are fabricated in order to substitute, support or improve the    
biological structures. Generally, such implants are composed of biocompatible materials (synthetic 
polymers and natural biopolymers, metals, metal alloys) depending upon their applications. In this 
regard, we fabricated a novel three dimensional calcium alginate bead based scaffold implant for 
drug delivery and tissue engineering applications. The scaffold was designed by placing the 
alginate beads in layer by layer arrangement allowing hexagonal closed packing. The designed 
scaffold was analyzed for its physico-chemical characteristics using SEM, FTIR, swelling 
behavior and drug release kinetics. Further, biological characterizations such as biocompatibility 
and antibacterial activity of the scaffolds were also carried out. The fabricated scaffold had dense 
and compact packing of the calcium alginate beads resulting in better mechanical strength. 
Analysis of release kinetics of model drug (Rhodamine) showed that the release rate of the drug 
was dependent on the number of layers stacked over each other. The scaffold implant was found 
to be biocompatible. Thus, we decipher that the scaffold implant could be used for drug delivery 
and tissue engineering applications. 
 
 
KEYWORDS: Sodium alginate, Rhodamine dye, scaffold, implant, biocompatibility, 
alginate beads.  
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1.1 Introduction: 
In recent years bioactive implants have started gaining attention. Biologically active implants 
are the system when placed in vivo interact with the system in a positive way that helps in restoring 
or repairing the damaged or traumatized tissue. Usually there are two types of biologically active 
implants; the first one is “Implants made up of metal or ceramics coated with bioactive molecules” 
(i.e. cell adhesion proteins, peptides, growth factors, drugs)[1]. The second type is “Tissue 
inductive scaffolds”[2]. 
Recently people have come up with a new hybrid system that possess the virtue of both the 
implants mentioned above. Such implants are prepared by loading the bioactive compounds in 
tissue engineered scaffold[3]. Beauty of this system is that it can contribute multiple therapeutic 
benefits simultaneously or following a desired spatiotemporal sequence. There are a number of 
such implants now in clinical practice including microsphere impregnated porous scaffold, 
microsphere impregnated hydrogel, nanoparticle loaded film, and different beads based systems.  
Examples of the implants now in clinical use: 
A porous collagen scaffold when impregnated with ciprofloxacin loaded gelatin 
microspheres, it is capable of delivering the drug at the wound site in a very controlled manner. 
Water-in-oil emulsion technique was used to prepare the ciprofloxacin loaded gelatin microspheres 
and were then impregnated in the collagen sponge[4]. The pore size of collagen sponge is in the 
range of 500 - 700 µm, which can encapsulate the gelatin microspheres. At the wound location the 
gelatin microspheres would degrade offering drug release at the wound surface and the collagen 
sponge acts as reservoir for gelatin microspheres; it also supports skin redevelopment. 
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 In another research gelatin microspheres were prepared containing basic fibroblast growth 
factor (bFGF) for its controlled release. When preadipocytes were implanted simultaneously with 
gelatin microspheres, they were able to induce adipose tissue development at the implanted site. 
After isolating preadipocytes from human adipose tissue, they were suspended with the gelatin 
microspheres which contained bFGF and were merged into a collagen sponge of cell scaffold[5].  
A novel and smart drug delivery system was developed comprising hydroxyl functionalized 
glycerol poly (ecaprolactone) (PGCL)-based microspheres and poly (N-isopropylacrylamide) 
(PNIPAAm) hydrogel. Several quantities PGCL based microspheres were introduced into poly (N-
isopropylacrylamide) (PNIPAAm) hydrogel[6]; which is temperature sensitive, to produce the 
novel drug delivery systems.  
Nanoparticle loaded thin films is used in active research’s for the longest period of time 
among these technologies. The unusual properties of metal nanoparticles are originated from 
quantum confinement effects and their large specific surface area. The applications of 
nanoparticles distributed in an organic matrix are: catalysis, magnetics, and photonics[7, 8]. The 
nanoparticle loaded polymer coating on colloidal particles is desired as colloidal particles can offer 
more surface area which is advantageous for a wide range of applications, such as catalysis and 
sensor applications[9]. 
Among these systems; the beads based system shows real promises because of its easy 
processing, small size, more volume, and more surface area to volume ratio. Smaller beads also 
offers advantages like; such as better conveyance of nutrients and oxygen, better mechanical 
strength, improved dispersion, easier grafting, and possible access to new implantation 
locations[10]. 
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The systems are already in use for cartilage tissue engineering[11], dual drug delivery (as 
in scaffold)[12], controlled release of multiple growth factors[13], protein delivery[14], controlled 
release of interleukin-2 for tumor immunotherapy[15], biodegradable cell carrier which helps in 
further tissue maturation[16]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
1.2 LITERATURE REVIEW: 
1.2.1 Bioactive Implants: 
Bioactive glass, bioactive calcium phosphate ceramics, bioactive glass ceramics, bioactive 
composites and coatings are the biomaterials that can bind to living tissue[17]. The biomechanical 
and biochemical compatibility of the materials can be optimized using two methods: (a) structural 
tailoring of bioactive materials[18] and (b) molecular tailoring of surface chemistry[19]. There are 
two types of bioactivities, osteoconductive and osteoproductive bioactivity, due to different 
mechanism and rates of implant-tissue interactions. The prostheses made up of bio-inert materials 
have the survivability half-life period of approximately 15 years (clinical applications are taken 
into account)[18]. Device lifetime can be improved with the help of bioactive materials but it has 
its limitations. Instead of this method use of hierarchical bioactive scaffolds or resorbable bioactive 
particulates or porous networks can be done to engineer in vitro living cellular constructs for 
transplantation and to activate in vivo the mechanisms of tissue regeneration. 
1.2.2 Implantable beads: 
The major disadvantages of parental antibiotic therapy for soft tissue infections, acute bone 
infections and osteomyelitis can be associated with ototoxic, nephrotoxic, can result high 
concentrations of serum and can also be allergic complications[20]. Due to these drawbacks 
antibiotic loaded biodegradable implants are in more use for bone infection treatment. 
Among a number of implants, the biocompatible and bioresorbable drug loaded beads are 
more in use for the treatment of tissue disorder. The drugs that can be loaded for various treatment 
can be; antibiotics for treatment of bone infection, antineoplastic substances for treatment of cancer 
and analgesics for relieve from pain etc.[21]. For insertion and better handling the beads can be 
attached to any bioresorbable junction. A good example of the bioresorbable material that can be 
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used for such type of applications is calcium sulfate, as it is biocompatible and has radiopaque 
property. Calcium sulfate beads can be used as bioresorbable void filler for bone or X-ray 
markers[22].  
One more use of implantable beads is that; wen the beads are made up of agarose and 
collagen or coated with agarose have been incorporated within cell samples. The cells produced 
biological products which are diffusible[23]. These beads can be arranged into an implant to 
control the recipient’s immune response. The beads can also be used in vitro to boost or suppress 
the growth of specific cells or to produce desired product from culture.  
Applications and Scopes: 
a) Beads that can be used as implant if contain agarose and collagen and if are coated with agarose 
if introduced into cells, they yield biological products which are diffusible. These beads can 
also be useful to control receiver’s immune reaction. The beads can also be used to enhance or 
suppress the growth of a particular cell in vitro and to produce the desirable result during cell 
culture. An example of such use was proved when the proliferation of the renal cancer cells 
was restricted by entrapping in the beads made up of material that suppresses cancer cell growth 
[24]. 
b) The beads made up of polymethylmethacrylate and incorporated with gentamicin had shown 
that the release rate can be very slow and the release time can be extended up to a time interval 
of several months and the concentration high enough to control the pathogens. The therapeutic 
efficiency of such drugs had been experimented on the model of osteomyelitis in the femur of 
hound. The tolerance was found to be sufficiently good in case of both tissue cultures and 
animal models. Gentamicin-PMMA beads insertion can be a valuable modern technology for 
local antibiotic therapy [25]. 
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c) An example of the above described method was when the radius of 77 rabbits were introduced 
with osteomyelitis and after 4 weeks the wound were debrided and the rabbits were treated 
with fatty acid dimersebacic acid beads loaded with 10-20% gentamicin sulfate or placebo 
beads and intramuscular gentamicin sulfate or only placebo beads or debridement only. Then 
again after 4 weeks the extinction of infection was determined by histological analysis and 
culturing. The animals treated with beads containing 20% gentamicin, among them 93% of 
animals were found to be osteomyelitis free, among the animals treated with beads containing 
10% gentamicin, 67% were found osteomyelitis free, in 25% of those cured with intramuscular 
gentamicin and placebo beads, in 12.5% of those treated with debridement only, and in 7% of 
those treated with placebo beads alone [26] . 
d) Another method among this techniques is the preparation of PLA biodegradable beads which 
can be impregnated with an ionic amino-glycoside and gentamycin. This process involves 
hydrophobic pairing of ions for solubilizing of gentamycin in a solvent which is compatible 
with poly-L-lactide (PLA), then precipitation with a compressed antisolvent (supercritical 
CO2) was done. The precipitate was found to be a homogeneous distribution of the ion 
combined drug in PLA microsphere. The bead sequences show no major change in release 
kinetics when sterilized with a H2O2 plasma. The gentamycin release kinetics from the PLA 
beads steady with the mechanism of matrix organized diffusion. Whereas the release rate of 
non-biodegradable PMMA beads were same as gentamycin initially and then ceases after 8-9 
weeks while the release in PLA beads continues for 4 months[27]. 
Advantages: 
The beads based system shows real promises because of; a) easy processing, b) small size, 
c) high drug loading capacity, and d) more surface area to volume ratio. Smaller beads also offer; 
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like i) better transportation of nutrients and oxygen, ii) better dispersion, iii) better mechanical 
strength, iv)easier implantation, and v) potential access to new implantation sites. 
1.2.3. Calcium Alginate Beads: 
1.2.3.1.  Sodium Alginate: Alginates are the chemicals extracted from the brown seaweeds 
and are available in ammonium, sodium and potassium derivatives. Alginates can be 
dissolved in both cold and hot water. It can also harden and bind.  In presence of any 
specific acid or calcium alginates can form tough gels. Sodium alginate is the sodium 
salt of alginic acid. It is in form of gum when removed from the cell walls of brown 
seaweed and can be used in food industries to increase viscosity. It can also be used as 
an emulsifier. It is also used as a component in indigestion tablets. It does not has any 
distinguishable flavor. It is a cold gelling agent which needs no external heat to gel, it 
dilutes while cold with strong agitation. However for the gel formation of this 
compound calcium compound is needed to be present. Usually calcium chloride is used 
to make caviar and spheres of alginate. Heat is not required to produce spherification. 
Sodium alginate can also be used for the formation of foams[28]. 
1.2.3.2. Calcium Alginate: It is a gelatinous, water-insoluble, and cream colored substance 
that can be formed by adding aqueous CaCl2 with aqueous Na. alginate. Calcium 
alginate is also in use for forming artificial seeds in plant tissue culture and entrapment 
of enzymes. The optimization and improvement of calcium alginate for possible use in 
endovascular occlusion was examined by analyzing it’s in vitro and in vivo 
biocompatibility and mechanical stability. The compressive rheology, resistance, and 
polymer profit of reacted alginate along with the polymer viscosity of unreacted 
alginate, were evaluated. Biocompatibility of calcium alginate had been established by 
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injecting it into the kidney capsule of mice. The reactivity of alginates with various 
compounds and at different levels of purity were associated histologically and visually. 
Consequences suggested that calcium alginate is a mechanically stable and 
biocompatible gel for endovascular uses. Refined alginates showed compressive 
strength of about 22 kPa and above at a level of 40% compression, with no major 
change in elasticity. Strength of Cleansed alginate was considerably greater than the 
crude alginates. The tissue reaction of purified alginates also presented considerably 
lower than that of crude alginates. Among all the alginates verified, cleansed high 
guluronic acid alginates showed ideal polymer return and strength, decreased viscosity, 
and increased biocompatibility. Medical embolization therapies can be developed with 
the progress of biocompatible and stable polymers like calcium alginate. Possible 
practices of upgraded endovascular polymers comprise vascular hemorrhaging, blood 
flow to tumors, aneurysms and treatment arteriovenous malformations i.e. AVMs [29]. 
1.2.3.3. Crosslinking Mechanism: The polymer of sodium alginate can be signified as it is 
represented in fig.1 (a).  
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Once sodium alginate has been put in a solution that contains calcium ions, then the 
calcium ions will replace the sodium ions in the polymer. Each calcium ion can confer 
maximum two of the polymer threads [30]. This mechanism is known as cross-linking 
and can be symbolized as given in fig.1 (b). 
 This crosslinking machinery is essential for converting sodium alginate to calcium 
alginate; a gelatinous substance which can be water-insoluble and is beneficial for a 
number of experiments. 
 
1.2.3.4.  Bead Formation: Alginate can form gels with a wide range of divalent cations. By 
the method of emulsification coupled with internal gelation technique spherical 
calcium alginate beads with uniform and small size were effectively prepared [31]. We 
can control the size and the size distribution of the beads by regulating process 
parameters. Additional research on preparation of alginate chitosan microspheres with 
the help of this technology for controlled release and loading of drugs in is still in 
progression.  
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2.1. OBJECTIVES: 
 Preparation of calcium alginate bead based scaffold 
 Physico-chemical characterization of scaffold 
 Potential application of the scaffold in drug delivery and tissue engineering 
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 2.2. WORKPLAN: 
 
 
 
  
Blank Calcium Alginate (CA) 
beads (1.5%) 
Arrangement of CA beads     
in HCP to form Layer 1. 
Application of 1% calcium 
Alginate solution evenly. 
Application of cross-linker 
for the binding of layers. 
Arrangement of CA beads     
in HCP to form the next 
Layer. 
Preparation of total implant by 
dipping the total structure in 1% 
CA and crosslinking it for 30 mins.  
Treating the solution with 0.1 
molar glycine for removal of 
unreacted glutaraldehyde. 
SEM 
FTIR 
Swelling  
Study 
Model drug 
Delivery 
Antimicrobial 
 Assay 
Mechanical 
Testing 
Hemocompatibility 
Biocompatibility 
Cell Migration 
Assay 
Preparation of Implant 
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3.1. Materials: 
Sodium Alginate (SA) was bought from SDFCL, Mumbai, India. Calcium Chloride (CaCl2, 
fused) was purchased from MERCK, Mumbai, India. The glutaraldehyde (25% aqueous solution) 
was procured from LOBA Chemie, Mumbai, India. Carboxymethly Cellulose Sodium (CMC) salt, 
Dulbecco’s Modified Eagle Media (DMEM), Dulbecco’s Phosphate Buffer Saline (DPBS), 
Trypsin EDTA Solution, Fetal Bovine Serum, Antibiotic-Antimycotic Solution, MTT Assay Kit 
and Nutrient Broth were purchased from Himedia, Mumbai, India. The MG63 cell line procured 
from NCCS, Pune. 
3.2 Methods: 
3.2.1. Preparation of Beads based implants: 
Calcium alginate beads were made by ionic gelation method by using 1.5% (w/v) 
sodium alginate and crosslinking solution containing calcium chloride (2% w/v) & 
glutaraldehyde (0.25% v/v). The implants were made by placing the CA beads in a layer by 
layer arrangement. CA beads were arranged in hexagonal closed packing over the glass slide to 
form a layer of x cm2 dimension. On this layer, 200 l of sodium alginate solution (1.5% w/v) 
was poured and was crosslinked by 200l of calcium chloride solution (2% w/v). Then, another 
layer of beads was placed over it and the process was repeated depending upon required number 
of bead layers. The structure thus formed was dipped in 1% (w/v) sodium alginate solution and 
finally placed in crosslinking solution [calcium chloride (2% w/v) + glutaraldehyde (0.25% 
v/v)] for 30 minutes. (protected for publication) The implant was then dipped in 0.1 molar 
glycine solution for another 60 minutes for neutralization of the uncrosslinked glutaraldehyde 
as it is toxic for cells [31]. 
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3.2.2. Scanning Electron Microscopy: 
The morphology of the dried implant was observed by field emission scanning electron 
microscope (FE SEM) (Nova NanoSEM 450). Prior to visualization, the samples were sputter 
coated with gold using sputter coater (Quorum Technologies, Q150RES). The scanning was 
performed at 5KV [32]. 
3.2.3. Fourier Transform Infrared Spectroscopy: 
The Fourier transform infrared spectroscopy (FTIR) of dried implant and pure sodium 
alginate powder was done using FTIR spectrophotometer AKTR (Shimadzu/IR prestige 21) 
using KBr pellet in the scanning range of 4000 – 400 cm-1[33]. 
3.2.4. Swelling Analysis: 
The swelling analysis of the dried and wet implants was done in Phosphate Buffer Saline 
(PBS, pH 7.4) and culture media with (% calcium content) at 37oC. For this, the implants were 
weighed and dipped in 25ml PBS [32]. At definite time, the implants were taken out, carefully 
blotted with filter paper and increase in weight of implants was measured using formula: 
Swelling Ratio (SW) = (Wt – W0) / W0  
Where, W0 and Wt represent initial weight of implant and weight of implant at time‘t’ 
respectively. 
 Moreover the change in the implant dimensions i.e., length, breadth and height were 
measured using a Vernier caliper (Fisher Scientific) to the nearest of 0.001mm. The measurements 
were taken at least at 3 random position for each dimension and the average value was reported. 
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3.2.5. Fabrication of Model drug loaded implant & Study of drug release: 
Rhodamine was used as a model drug for the study of release kinetics. For this, the middle 
layer of the implant was formed by Rhodamine loaded beads at different concentrations of 
10,000l, 1,000l, 500l, 400l, 300l, 200l, 100l, 50l, 10l and 0l and then the implant 
was fabricated in a similar way as described before [32]. The implants were placed in the center 
of petridishes filled with 0.6% concentration of agarose gel as it mimics the tissue. Photographs 
of these implants were taken using camera in Gel documentation system after some interval of 
time for seven days and further image analysis of loading and release of Rhodamine in the 
structures were done by NIH ImageJ software. (protected for publication) The release of dye 
was observed for both three layer and five layer implant structures. 
3.2.6. Study of drug release from the implant: 
Metronidazole loaded implant, fabricated in a similar way as discussed in the section [2.2.5] 
was evaluated for its antibacterial activity against Escherichia coli using agar diffusion method. 
For this, UV sterilized fresh implant was placed in a 90mm petri dish. Thereafter, the petri was 
filled with nutrient agar and allowed to solidify. Further, 50l of E. coli culture was spread onto 
the plate and was kept for incubation at 37oC for overnight. The extent of release of drug was 
determined by the zone of inhibition [34]. 
3.2.7. Mechanical Testing of implant: 
Prepared substrates were characterized for compression and stress relaxation profile using 
TA.XT2i Texture Analyzer (Stable Micro Systems Ltd, Surrey, UK). Substrate stiffness was 
calculated in terms of the modulus of deformability using compression data. 
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Table. 1: The parameters used while testing mechanical properties 
Type of study    Type of 
fixture 
Pre-test 
speed 
Test speed Post-test 
speed 
Mode of study 
Stress relaxation 3mm probe 1mm/sec 1mm/sec 1mm/sec Auto (Force) 
5g,3mm 
Compression 30mm probe 1mm/sec 1mm/sec 1mm/sec Auto (Force) 
5g,30mm 
 
3.2.8. Hemocompatibility: 
 The hemocompatibility of the CA implant was analyzed using fresh goat blood. In brief, 
the whole goat blood was diluted in 1:1 ratio using normal saline (0.89% NaCl). Thereafter, 
0.5ml of leachant from CA implant was added to diluted blood sample. The positive and 
negative controls were prepared by placing 0.5ml of 0.1N HCl and normal saline respectively 
instead of test samples. The samples were then centrifuged at 1000rpm and the percentage 
hemolysis was analyzed by measuring the absorbance at 545nm using UV-visible 
spectrophotometer. The leachant preparation was carried out by placing implant (1cm x 1cm x 
1cm) in PBS (pH 7.4) at 37oC overnight, followed by centrifugation at 3000rpm and the 
supernatant was used for the analysis [35]. 
3.2.9. Biocompatibility: 
The biocompatibility of fabricated implant was analyzed against HaCaT cell line 
(human keratinocytes) using the leachant. In brief, the cell line was maintained in DMEM with 
10% FBS in a humidified (95%), CO2 incubator (5%) at 37
oC. Cells were harvested, evaluated 
for their viability and seeded in a 96 well plate at a concentration of 1x105cells/ml. Further, 20 
l of filter sterilized leachant was added in each well. The leachant was prepared by placing 
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implant in PBS (pH 7.4) at 37oC overnight. The sample was then centrifuged at 3000rpm and 
supernatant was used for the analysis. The culture plate was then incubated for next 24 hours 
and cytotoxicity of leachant was analyzed using MTT Assay. The same protocol was followed 
to optimize the neutralization time of glutaraldehyde. For this, the implants were neutralized for 
various time intervals (0, 2, 4, 6, 24 hours) using 0.1M glycine prior to leachant preparation and 
the cell viability was evaluated for each [36].  
3.2.10. Cell Migration Assay: 
The cell migration into the fabricated implant was evaluated using MG63 cell line (human 
osteosarcoma). For this, the implants were fabricated, crosslinked, neutralized, equilibrated with 
DMEM media for next 24 hours and seeded with MG63 cells under sterile conditions as 
explained in section [2.2.1]. The MG63 cells were maintained in DMEM with 10% FBS in a 
humidified (95%), CO2 incubator (5%) at 37
oC. Cells were harvested, evaluated for their 
viability and seeded onto the implant a concentration of 1x106 cells/ml. At definite time interval, 
the cell viability was evaluated using MTT assay. [36] 
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4.1. RESULTS: 
4.1.1. Fabrication of CA bead based implant: 
Alginate beads have been prepared by a number of research groups for the delivery of 
drugs, proteins and peptides. However, calcium alginate beads based implants has not been in 
a wide use. In the process of preparation; the beads were arranged in a hexagonal close packing 
as it is their property. The beads are placed in layer by layer form, one above the other. Binding 
was only be solution and crosslinked with glutaraldehyde solution.  Then to remove the external 
glutaraldehyde binding it was treated with Glycine for 60 minutes. (protected for publication) 
The structure was found to be stable and handling as compared to beads became easier. By 
placing the structures at 37 0C for 24 hours, it dried completely. Upon drying the structures 
shrunk to a very compact form[12]. 
Fig. 1: (a) fabrication of beads and scaling, (b) Hexagonal close packing of beads, (c) 
Hexagonal close packing of normal beads and Rhodamine loaded beads,   
(d), (e) implant fabrication and scaling, (f) Scaling of dried implants 
 
              (a)                                                 (b)                                             (c) 
          (d)                                             (e)                                          (f) 
(protected for publication) 
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4.1.2. Scanning Electron Microscopy: 
Fig. 2: Surface morphology of CA bead implant 
Analysis of surface morphology of dried structures by Scanning Electron Microscopy 
showed that the beads in the structures are closely bound together by hexagonal close packing. 
The distance between two consecutive beads was found to be 9.862 m. (protected for 
publication) The beads in the center of the structure are intact but at the edges they were almost 
squeezed have formed a wrinkled surface [32]. 
4.1.3. Fourier Transform Infrared Spectroscopy: 
FTIR spectra analysis of pure SA and the formulated implant demonstrated the presence of 
characteristic peaks at 1620cm-1, 1420cm-1 and 1306cm-1 corresponding to symmetric and 
(protected for publication) 
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asymmetric vibrations of carboxylate ions in SA. Broad peak near 3400cm-1 corresponds to OH 
stretching mode. The peaks present in 1200-1000 cm-1 region represents the absorption due to 
sugar ring. It is important to mention that the similar peaks were observed in case of calcium 
alginate implant. However the percentage absorption of the peaks tends to increase. This may 
be a result of polymeric chains of alginate by calcium and glutaraldehyde [33]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: FTIR Analysis 
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4.1.4. Swelling Analysis: 
The swelling analysis of dried and swollen implant was carried out in PBS at the 
physiological pH 7.4. The swollen structure did not show much increase in the swelling ratio. 
It is important to mention that during initial three hours of analysis, the swelling ratio of the 
swollen structure decreased (tending towards negative). This may occur as a result of 
equilibrium maintenance between the structure and the surrounding medium. (protected for 
publication). Thereafter the swelling ratio increased with time till 48 hours of study and then 
decreased due to disintegration of the structure. A similar trend was observed for the changes 
in dimensions of the swollen structure. (protected for publication). Dried structure demonstrated 
fast swelling for initial few hours of analysis. Thereafter, swelling of structure occurred at a 
steady rate. During swelling, the dried implant retained its structural integrity and disintegrated 
after a span of 96 hours [32]. 
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(c) 
Fig. 4. (a) Swelling ratio of dried implant, (b) Swelling ratio of swollen implant 
(c) Relative change in dimensions for swollen implant 
 
The swelling analysis of swollen implant was also carried out in culture media at the 
physiological pH 7.4. The swollen structure showed much higher increase in the swelling ratio 
as compared to in PBS. (protected for publication)  Thereafter the swelling ratio increased with 
time; in the beginning it increased in a very high ratio thereafter in a very uniform way. During 
swelling, the implant retained its structural integrity and disintegrated after a span of 48 hours 
[32].  
 
  
 
 
(a)                                                                 (b) 
Fig. 5: (a) Swelling ratio for swollen implant, (b) Relative change in dimensions of swollen 
implant 
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4.1.5. Fabrication of Model drug loaded implant & its release study: 
  In case of scaffolds, the homogeneous distribution of drugs is very difficult to attain. The 
scaffolds which are designed by freeze drying or salt leeching method have a very random non-
spatial distribution of drugs. In a definite time interval, implant having more numbers of bead 
layers showed greater interlayer release of the drug before it is dispersed into the surroundings, 
hence giving a lag time in its release [35]. 
 
(a) 
(protected for publication) 
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                                                                    (b)                                                                              (c) 
Fig. 6: (a) Analysis of Rhodamine diffusion from bead implants to agarose after 7 days, (b) 
Analysis of intensity profile from center towards periphery as a function of distance, (c) 
Intensity scale for fig. 6(b)  
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4.1.6. Drug loaded implant & its release study: 
When the anti-bacterial analysis was completed on the CA implants each gave a clear zone 
of inhibition. The drug used for this study was metronidazole. The zone of inhibition around the 
metronidazole implant was due to the release of the same by diffusion. The test was carried out 
for both 3 and 5 layered implants. A remarkable difference was observed in the zone of 
inhibition due to the release of the drug in 3 and 5 layered implants (p < 0.005). The release rate 
was faster in the 3 layered implant (fig. 7(b)) than the 5 layered implant (fig.7(a)), following the 
fashion similar to that of the model drug (i.e. Rhodamine) release [34]. (protected for 
publication) 
(a)                                                    (b) 
Fig. 7: Zone of inhibition for metronidazole loaded implants after 24hrs 
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4.1.7. Mechanical Testing of implants:  
      (a)                                                                                  (b) 
Fig. 8: (a) Compression Analysis, (b) Stress relaxation Analysis
Mechanical properties are important for handling and processing of the implants. The 
mechanical properties of the implants were evaluated on the basis of ‘compression’ and ‘stress 
relaxation’. Percentage stress relaxation of the implants was found to be 90.30%. After calculating 
from the compression graph the Young’s modulus of deformation was found to be 5.75 KPa [34]. 
(protected for publication). 
 
 4.1.8. Hemocompatibility: 
To determine if a sample is suitable for in vivo applications the interaction of the polymeric 
origination with blood is necessary parameter. Usually the hemolysis percentage caused by the 
polymer is the primary criteria to measure its hemocompatibility. The result found from our 
experiment confirmed that the CA implants are greatly hemocompatible with a percentage 
hemolysis of about 3% [35]. 
(protected for publication) 
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Fig. 9: Hemocompatibility Analysis of CA implants 
 
4.1.9. Biocompatibility: 
 When the integration of the implants were considered with the tissue, it is important to 
estimate the interactions of the implant with the cells. If an implant supports the cells while 
adhering and proliferating and does not cause any cytotoxic effect then it can be considered as 
biocompatible. In our study the CA implants were found to be biocompatible with a cell 
proliferation index greater than 95%..(protected for publication)  Though, due to the presence 
of unbound glutaraldehyde restricts the compatibility of the implant because of its cytotoxic 
properties. Therefore, it is extremely vital to counteract the unbound glutaraldehyde by 0.1M 
glycine; still the time of treatment needs to be optimized [36].  
(protected for publication) 
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Fig. 10: Biocompatibility analysis of CA bead based implants 
4.1.9. Cell Migration Assay: 
 A cellular scaffold should contain good population of cells required. The present cell 
seeding method failed to confirm such standardized seeding; particularly for scale of higher 3D 
volume. In these type of cases cell migration from external environment to inside of scaffold 
can only guarantee standardized cell populations. This is the reason for fabricating scaffolds 
having significant porosity. This is one of the major reason of making scaffold having 
significant pore size and porosity.  From the point of view of tissue engineering a 
microarchitecture like this which helps the migration of the cells inside the scaffold is 
advantageous. In this study, we have designed a bead based scaffold with homogenous certain 
porous structure. Due to the distribution of formazan dye (MTT assay), it is observed that cells 
migrated downwards from the top surface of the scaffold sustaining a steady rate of migrations. 
The density profiling of the scaffold further presented a rise in cell population with time in the 
internal environment of the scaffold [36]. (protected for publication). 
(protected for 
publication) 
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Fig. 11: Cell migration within the bead based scaffold at day 1, day 3 and day 5  
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CHAPTER 5 
CONCLUSION 
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5. Conclusion: 
In this study, we successfully fabricated the Calcium Alginate beads based implants that 
could present a potential candidature for controlled drug delivery and tissue engineering 
application. The bead based implant is a novel structural design wherein each bead could be taken 
as a single unit of the implant making it more flexible in term of its design and mode of application. 
The analysis demonstrated that the structure was highly biocompatible, highly hemocompatible 
and demonstrated good stress relaxation properties. The drug release from the implant could be 
controlled easily as a function of number of bead layers in implant. However, the applications of 
the implant need a proper validation in in vivo system. 
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